
David B. Sykes, MD, PhD, discusses the rationale for exploring the oral CXCR4 antagonist mavorixafor in patients with chronic neutropenia.

David Sykes, MD, PhD, is an associate physician of medicine-hematology and medical oncology at Massachusetts General Hospital, a clinician investigator and assistant professor at Mass General Brigham Cancer Institute Classical Hematology Massachusetts General Physicians Organization of Mass General Research Institute; and an assistant professor of medicine at Harvard Medical School.